000 | 01988 a2200553 4500 | ||
---|---|---|---|
005 | 20250514225007.0 | ||
264 | 0 | _c20060609 | |
008 | 200606s 0 0 eng d | ||
022 | _a1531-5037 | ||
024 | 7 |
_a10.1016/j.jpedsurg.2004.09.020 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBond, Geoffrey J | |
245 | 0 | 0 |
_aEvolutionary experience with immunosuppression in pediatric intestinal transplantation. _h[electronic resource] |
260 |
_bJournal of pediatric surgery _cJan 2005 |
||
300 |
_a274-9; discussion 279-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 |
_aCytomegalovirus Infections _xetiology |
650 | 0 | 4 | _aDaclizumab |
650 | 0 | 4 |
_aEpstein-Barr Virus Infections _xetiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _xetiology |
650 | 0 | 4 | _aGraft Survival |
650 | 0 | 4 |
_aGraft vs Host Disease _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aIntestinal Diseases _xsurgery |
650 | 0 | 4 |
_aIntestines _xtransplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOrgan Transplantation _xadverse effects |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
650 | 0 | 4 | _aTransplantation Conditioning |
700 | 1 | _aMazariegos, George V | |
700 | 1 | _aSindhi, Rakesh | |
700 | 1 | _aAbu-Elmagd, Kareem M | |
700 | 1 | _aReyes, Jorge | |
773 | 0 |
_tJournal of pediatric surgery _gvol. 40 _gno. 1 _gp. 274-9; discussion 279-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpedsurg.2004.09.020 _zAvailable from publisher's website |
999 |
_c15534740 _d15534740 |